ZYDUS WELLNESS LTD.-$ - 531335 - Closure of Trading Window
Intimation of Closure of Trading Window.23-09-2021
23-09-2021
Zydus to sell two brands to PE firm True North's portfolio company
Both drugs, Mifegest Cytolog are used for medical termination of pregnancy20-09-2021
Zydus Wellness Ltd - 531335 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Participation in in Motilal Oswal Annual Global Investor Conference call scheduled on September 14, 2021.09-09-2021
ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) Details of Loss of Share Certificate.02-09-2021
Zydus Wellness Ltd - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) Details of Loss of Share Certificate.02-09-2021
Zydus Wellness Ltd - 531335 - Intimation Under Regulation 7(2) Of PIT Regulations.
Intimation under regulation 7(2) of PIT Regulations.27-08-2021
Zydus expects Rs 200-250 crore monthly sales of ZyCoV-D vaccine from October quarter
The company said it is in discussions with the government on pricing and volumes of the needle-free COVID vaccine and expects to roll out one crore doses per month from October.24-08-2021
Zydus to soon start work on developing a vaccine for Delta variant
Also plans trials for children aged three years and above. Its needle-free injection is to be assembled in India22-08-2021
Zydus to start supplies of needle-free vax by Sept-end
New plant may produce one-crore doses a month from October21-08-2021